Haruhiko Motegi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

A Case of Wild-type Transthyretin Amyloidosis with Amyloid Deposition in the Intervertebral Disc.

A Case of Wild-type Transthyretin Amyloidosis with Amyloid Deposition in the Intervertebral Disc.

Journal: Internal medicine (Tokyo, Japan)

Published: April 29, 2026

External validation of six prediction scores for differentiating intracranial atherosclerotic disease-related large vessel occlusion from embolic large vessel occlusion.

External validation of six prediction scores for differentiating intracranial atherosclerotic disease-related large vessel occlusion from embolic large vessel occlusion.

Journal: European journal of radiology

Published: April 20, 2026

Neuromyelitis optica spectrum disorder in a patient with neurofibromatosis type 1 mimicking spinal cord infarction.

Neuromyelitis optica spectrum disorder in a patient with neurofibromatosis type 1 mimicking spinal cord infarction.

Journal: Practical neurology

Published: April 08, 2026

Multiple Sclerosis With Migraine and Pyoderma Gangrenosum Treated With Ofatumumab and Erenumab.

Multiple Sclerosis With Migraine and Pyoderma Gangrenosum Treated With Ofatumumab and Erenumab.

Journal: Cureus

Published: January 19, 2026

Reduced cerebrospinal fluid taurine is associated with nigrostriatal dopaminergic deficits in drug-naïve Parkinson's disease.

Reduced cerebrospinal fluid taurine is associated with nigrostriatal dopaminergic deficits in drug-naïve Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: July 21, 2025

Sleep disturbance is associated with worsening quality of life in patients with multiple system atrophy.

Sleep disturbance is associated with worsening quality of life in patients with multiple system atrophy.

Journal: Clinical neurology and neurosurgery

Published: January 12, 2025

Sustained Minimal Manifestations With Extended Interval Dosing of Efgartigimod in Seronegative Myasthenia Gravis: Case Report.

Sustained Minimal Manifestations With Extended Interval Dosing of Efgartigimod in Seronegative Myasthenia Gravis: Case Report.

Journal: Muscle & nerve

Published: December 19, 2024

Predictors of achieving minimal manifestations or better status in ocular myasthenia gravis with immunotherapy.

Predictors of achieving minimal manifestations or better status in ocular myasthenia gravis with immunotherapy.

Journal: Journal of neurology

Published: December 13, 2024

Anti-mitochondrial M2 antibody-positive myositis may be an independent subtype of autoimmune myositis.

Anti-mitochondrial M2 antibody-positive myositis may be an independent subtype of autoimmune myositis.

Journal: Journal of neurology

Published: October 26, 2024

Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient Mice.

Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient Mice.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 24, 2024

B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis.

B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis.

Journal: Frontiers in immunology

Published: February 05, 2024

Urinary Immunoglobulin G Is a Novel Biomarker for Atherosclerotic Burden in Mild Acute Ischemic Stroke Patients.

Urinary Immunoglobulin G Is a Novel Biomarker for Atherosclerotic Burden in Mild Acute Ischemic Stroke Patients.

Journal: Journal of atherosclerosis and thrombosis

Published: September 13, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026